Mazindol is an appetite suppressant used to treat obesity. It works by stimulating the central nervous system (CNS) to decrease appetite. It is usually used in combination with a reduced-calorie diet and exercise to help people lose weight. It is only available with a doctor's prescription.
Mazindol is a stimulant medication with a complex history of use. Here's a breakdown of the key points:
Primary Use:
- Historically, mazindol was used as an appetite suppressant for weight management [Drugs.com].
Current Status:
- In the United States, mazindol is not currently marketed or FDA-approved for weight loss [PubChem].
- There's one approved use for mazindol in the US for a different condition: Duchenne muscular dystrophy [PubChem].
Potential Uses (outside of the US):
- In some countries, mazindol might still be prescribed for short-term weight management, typically alongside lifestyle changes like diet and exercise, for people with a Body Mass Index (BMI) above 30 or exceeding 27 with additional risk factors [Drugs.com].
- There are also ongoing studies investigating its effectiveness for Attention Deficit Hyperactivity Disorder (ADHD) [Wikipedia].
How it Works:
- Mazindol acts as a sympathomimetic amine, stimulating the central nervous system (CNS) [Drugs.com]. This can lead to:
- Increased heart rate and blood pressure
- Decreased appetite
Important Considerations:
- Due to its stimulant properties, mazindol can cause side effects such as anxiety, insomnia, irritability, and headaches [Drugs.com].
- There are potential interactions with other medications, especially antidepressants like MAOIs [Drugs.com].
- Mazindol is a DEA Schedule IV controlled substance, indicating some potential for abuse but lower than Schedule III drugs [PubChem].
Anatomical Therapeutic Chemical Classification
A - Alimentary tract and metabolism
A08 Antiobesity preparations, excluding diet products
A08A - Antiobesity preparations, excluding diet products
A08AA Centrally acting antiobesity products
ATC Code
External Links